Across TCGA pan-cancer cohorts, KRT16P1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated KRT16P1 data layer compared with 16 for mass-spec protein.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher KRT16P1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated KRT16P1 expression acts as an unfavorable survival marker.

LIHC are the cancer types where KRT16P1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	III,IV	0.051	0.738	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: KRT16P1 tumor-vs-normal RNA expression · all KRT16P1 data types